Conmed (CNMD) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures gain as oil pulls back ahead of Fed decision
- Nvidia to commit $3 bln to Meta share offering as part of bigger AI partnership
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Boeing free cash flow beats estimates despite production challenges
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $47.68 --0%
EPS Growth %: -7.4%
Financial Fact:
Net sales: 184.79M
Today's EPS Names:
OMID, SICP, SCKT, More
EPS Growth %: -7.4%
Financial Fact:
Net sales: 184.79M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q4 EPS of $1.07, $0.01 better than the analyst estimate of $1.06. Revenue for the quarter came in at $274 million versus the consensus estimate of $278.76 million.
GUIDANCE:
Conmed sees FY2022 EPS of $3.60-$3.85, versus the consensus of $3.74. Conmed sees FY2022 revenue of $1.075-1.125 billion, versus the consensus of $1.11 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CTS Corp. (CTS) Tops Q3 EPS by 10c ; Offers Guidance
- Freeport beats Q3 estimates on higher copper, gold prices
- Corning shares rise 3% in premarket trade after Q3 EPS, revenue beat estimates
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
